Litcius/Paper detail

Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors

Vincenzo Formica, Cristina Morelli, Anna Patrikidou, C. Murias, Sabeeh Butt, A. Nardecchia, Jessica Lucchetti, Nicola Renzi, Kai‐Keen Shiu, Mario Roselli, Hendrik‐Tobias Arkenau

2020Targeted Oncology20 citationsDOI

Topics & Concepts

MedicineNomogramInternal medicineGastroenterologyHazard ratioProportional hazards modelCancerQuartileC-reactive proteinOncologyInflammationConfidence intervalInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersEsophageal Cancer Research and Treatment
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors | Litcius